Sign Up to like & get
recommendations!
0
Published in 2018 at "Nature"
DOI: 10.1038/s41586-018-0125-z
Abstract: Somatic mutations in tet methylcytosinedioxygenase 2 (TET2), which encodes an epigenetic modifier enzyme, drive the development of haematopoietic malignancies1–7. In both humans and mice, TET2 deficiency leads to increased self-renewal of haematopoietic stem cells with…
read more here.
Keywords:
pre leukaemic;
tet2;
pmp;
microbial signals ... See more keywords